Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ejphar.2020.173372 http://scihub22266oqcxt.onion/10.1016/j.ejphar.2020.173372 32682787!7366101!32682787     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+J+Pharmacol 2020 ; 883 (ä): 173372 Nephropedia Template TP {{tp|p=32682787|t=2020. Advances in the possible treatment of COVID-19: A review |pdf=|usr=}}{{32682787}} gab.com Text Advances in the possible treatment of COVID-19: A review JO: Eur J Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=32682787 #FOAvip The emergence of the global pandemic caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its prevention and treatment. Despite the unprecedented advances in the modern medicinal system, currently, there are no proven effective therapies. However, rapid research on SARS-CoV-2 epidemiology help unveiling some new targets for potential drug therapies. Many drugs have been screened, and even their clinical trials are going on at an exceptional pace. Amongst these RNA-dependent RNA polymerase inhibitors (favipiravir and remdesivir) and steroids especially dexamethasone showed promising effects. The biological agents like tocilizumab, interferons, and convalescent plasma prove to be beneficial in viral clearance. Moreover, many immunomodulatory and viral S protein targeting vaccines have their ongoing clinical trials. The establishment of various in vitro and in vivo models for preclinical studies can additionally help the current research. The volume and the pace of the clinical trials launched to evaluate the safety and efficacy of various agents against coronavirus disease 2019 (COVID-19) reflect the need for high-quality evidence for various therapies to be practiced by clinicians. This study aims to sum up all the current advances in the global medicinal system against the COVID-19. Twit Text FOAVip Advances in the possible treatment of COVID-19: A review ????Eur J Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=32682787 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32682787 #FOAvip English Wikipedia <ref>{{Cite pmid|32682787}}</ref> Advances in the possible treatment of COVID-19: A review #MMPMID32682787 Chibber P; Haq SA; Ahmed I; Andrabi NI; Singh G Eur J Pharmacol 2020[Sep]; 883 (ä): 173372 PMID32682787show ga The emergence of the global pandemic caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its prevention and treatment. Despite the unprecedented advances in the modern medicinal system, currently, there are no proven effective therapies. However, rapid research on SARS-CoV-2 epidemiology help unveiling some new targets for potential drug therapies. Many drugs have been screened, and even their clinical trials are going on at an exceptional pace. Amongst these RNA-dependent RNA polymerase inhibitors (favipiravir and remdesivir) and steroids especially dexamethasone showed promising effects. The biological agents like tocilizumab, interferons, and convalescent plasma prove to be beneficial in viral clearance. Moreover, many immunomodulatory and viral S protein targeting vaccines have their ongoing clinical trials. The establishment of various in vitro and in vivo models for preclinical studies can additionally help the current research. The volume and the pace of the clinical trials launched to evaluate the safety and efficacy of various agents against coronavirus disease 2019 (COVID-19) reflect the need for high-quality evidence for various therapies to be practiced by clinicians. This study aims to sum up all the current advances in the global medicinal system against the COVID-19. |*Coronavirus Infections/drug therapy/epidemiology/prevention & control[MESH] |*Drug Development[MESH] |*Drug Discovery[MESH] |*Pandemics/prevention & control[MESH] |*Pneumonia, Viral/drug therapy/epidemiology/prevention & control[MESH] |Antiviral Agents/*pharmacology[MESH] |Betacoronavirus/drug effects[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19 Vaccines[MESH] |Humans[MESH] |SARS-CoV-2[MESH]Advances in the possible treatment of COVID-19: A review (epmc).pdf DeepDyve Pubget Overpricing